|
|
|
|
GMMMG Consultations |
|
|
On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below. Due to the COVID-19 outbreak all active GMMMG consultations have been suspended as of Wednesday 1st April 2020. This will continue until the end of June 2020 initially, when this position will be reviewed. We will continue to accept comments on these documents during this time, but no new consultations will be opened. Please direct any questions to nuth.enquires.gmmmg@nhs.net. |
|
|
Title |
Information |
Feedback |
End date |
|
|
86 |
PaGDSG - SCP for mycophenolate for interstitial lung disease |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated Greater Manchester wide Shared Care Protocol for mycophenolate for interstitial lung disease is in development. We now seek the comments on this draft. This consultation period is open until 5pm on Wednesday 29th April 2020. |
June 2020 |
|
|
85 |
PaGDSG - SCP for Amiodarone for Severe Rhythm Disorder in Adults |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an new Greater Manchester wide Shared Care Protocol for Amiodarone for Severe Rhythm Disorder in Adults is in development. We now seek the comments on this draft. This consultation period is open until 5pm on Monday 27th April 2020. |
June 2020 |
|
|
84 |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated Greater Manchester wide Shared Care Protocol for methotrexate for interstitial lung disease is in development. We now seek the comments on this draft. This consultation period is open until 5pm on Wednesday 22nd April 2020 |
June 2020 |
||
|
83 |
PaGDSG - SCP for hydroxychloroquine for interstitial lung disease |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester wide Shared Care Protocol for hydroxychloroquine for interstitial lung disease is in development. We now seek the comments on this draft. This consultation period is open until 5pm on Wednesday 22nd April 2020. |
June 2020 |
|
|
82 |
The following FMESG actions for February 2020 have been proposed. We now seek comments on these proposals. This consultation is open until 5pm on Monday 20th April. |
June 2020 |
||
|
81 |
GMMMG Guidance for the Covert Administration of Medicines in Care Home Settings |
Draft guidance for the Covert Administration of Medicines in Care Home Settings has been developed by the GM Covert Medicines Task and Finish Group. It will form part of a larger GM policy on the Principles of Safe Medicine Administration in Care Settings. We now seek comments on this draft. This consultation period is open until 5pm on Friday 3rd April. |
June 2020 |
|
|
80 |
The following FMESG actions for January 2020 have been proposed. We now seek comments on these proposals. This consultation is open until 5pm on Monday 30th March. |
5pm Monday |
||
<< Back
